Drugs (Pharmaceuticals) – Page 11

Biden Officials Stave Off Sticker Shock on Medicare Drug Premiums

Federal regulators spent billions of dollars to avoid a spike in costs for older Americans that could have been politically damaging to the presidential campaign of Vice President Kamala Harris.

By Rebecca Robbins and Reed Abelson

Bristol Myers Squibb Company Clinical Trials Dopamine Drugs (Pharmaceuticals) Food and Drug Administration Karuna Therapeutics Inc Psychiatry and Psychiatrists Psychology and Psychologists Regulation and Deregulation of Industry Research Schizophrenia Therapy and Rehabilitation Weight

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

By Ellen Barry and Christina Jewett

Deaths (Fatalities) Developing Countries Drug Resistance (Microbial) Drugs (Pharmaceuticals) General Assembly (UN) Infections Lancet, The (Journal) Medicine and Health Poverty Shortages

The Global Threat of Antibiotic Resistance

International health experts have begun to shift their focus to try to provide access to basic drugs in countries where preventable deaths from infections occur too frequently.

By Andrew Jacobs

AstraZeneca PLC Drugs (Pharmaceuticals) Food and Drug Administration Influenza Vaccination and Immunization

Nasal Flu Vaccine Is Approved for At-Home Use

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.

By Christina Jewett